Concepedia

Publication | Open Access

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial

DOIFull Paper Access

269

Citations

26

References

2021

Year

Johann S. de Bono, Niven Mehra, Giorgio V. Scagliotti, Elena Castro, Tanya B. Dorff, Adam Stirling, Arnulf Stenzl, Mark T. Fleming, Celestia S. Higano, Fred Saad,
The Lancet Oncology

References

YearCitations

Page 1